BackApellis Pharmaceuticals Overview
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Target Price

Analysts' 12-month price predictions for APLS.

Share Price

$18.39

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-11-06H.C. WainwrightDouglas Tsao$57210% upsideOpen
2024-09-23Robert W. BairdColleen Kusy$92400.3% upsideOpen
2024-09-20Stifel NicolausAnnabel Samimy$84356.8% upsideOpen
2024-09-20Mizuho SecuritiesGraig Suvannavejh$39112.1% upsideOpen
2024-09-16Mizuho SecuritiesGraig Suvannavejh$42128.4% upsideOpen
2024-08-09Robert W. BairdColleen Kusy$96422% upsideOpen
2024-08-08JefferiesAkash Tewari$82345.9% upsideOpen
2024-08-02H.C. WainwrightDouglas Tsao$83351.3% upsideOpen
2024-07-26Robert W. BairdColleen Kusy$86367.6% upsideOpen
2024-07-01Mizuho SecuritiesGraig Suvannavejh$49166.4% upsideOpen
2024-05-23Wells FargoDerek Archila$48161% upsideOpen
2024-02-05JefferiesAkash Tewari$80335% upsideOpen
2023-01-02Wells FargoDerek Archila$58215.4% upsideOpen
2022-11-15J.P. Morgan$79329.6% upsideOpen
2022-09-12Wedbush$67264.3% upsideOpen
2022-09-08Stifel Nicolaus$65253.5% upsideOpen
2022-08-18Oppenheimer$78324.1% upsideOpen
2022-08-09Credit Suisse$52182.8% upsideOpen
2022-08-09Goldman Sachs$102454.6% upsideOpen
2022-08-09Raymond James$113514.5% upsideOpen
2022-07-20Citigroup$86367.6% upsideOpen
2022-06-23Stifel NicolausAnnabel Samimy$60226.3% upsideOpen
2022-05-24Goldman Sachs$84356.8% upsideOpen
2022-05-05Credit Suisse$44139.3% upsideOpen
2022-05-05Raymond James$102454.6% upsideOpen
2021-11-09WedbushLaura Chico$2852.3% upsideOpen
2021-11-09BMO CapitalMatthew Luchini$69275.2% upsideOpen
2021-10-01JefferiesChris Howerton$74302.4% upsideOpen
2021-10-01Cantor FitzgeraldAlethia Young$74302.4% upsideOpen
2021-09-10Credit SuisseTiago Fauth$38106.6% upsideOpen
2021-07-01Cowen & Co.Phil Nadeau$70280.6% upsideOpen